• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.通过时间杀菌动力学研究比较喹诺酮类抗生素和万古霉素对庆大霉素耐药及耐甲氧西林金黄色葡萄球菌的体外活性。
Antimicrob Agents Chemother. 1986 Dec;30(6):823-7. doi: 10.1128/AAC.30.6.823.
2
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.A-56619、A-56620、阿米氟沙星、环丙沙星、依诺沙星、诺氟沙星和氧氟沙星对耐甲氧西林金黄色葡萄球菌的体外比较
Antimicrob Agents Chemother. 1986 Feb;29(2):325-6. doi: 10.1128/AAC.29.2.325.
3
Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.针对耐甲氧西林和/或耐庆大霉素及敏感葡萄球菌的新型药物。
Chemotherapy. 1989;35(5):333-7. doi: 10.1159/000238691.
4
Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.喹诺酮类药物对环丙沙星敏感及环丙沙星耐药的耐甲氧西林金黄色葡萄球菌的不同活性。
Antimicrob Agents Chemother. 1991 Feb;35(2):345-50. doi: 10.1128/AAC.35.2.345.
5
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.采用时间杀菌法对青霉素G、RP 59500、红霉素、司帕沙星、环丙沙星和万古霉素的抗肺炎球菌活性进行比较研究。
Antimicrob Agents Chemother. 1994 Sep;38(9):2065-72. doi: 10.1128/AAC.38.9.2065.
6
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.通过杀菌动力学研究确定LY146032与甲氧西林、头孢唑林、头孢孟多、头孢呋辛、环丙沙星和万古霉素对葡萄球菌的活性比较。
Antimicrob Agents Chemother. 1987 Aug;31(8):1210-5. doi: 10.1128/AAC.31.8.1210.
7
In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.司帕沙星及其他三种氟喹诺酮类药物对耐甲氧西林金黄色葡萄球菌和表皮葡萄球菌的体外活性
Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):55-8. doi: 10.1007/BF01971273.
8
Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.环丙沙星对耐甲氧西林金黄色葡萄球菌的活性。
Antimicrob Agents Chemother. 1985 May;27(5):688-91. doi: 10.1128/AAC.27.5.688.
9
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.去氟(6)-喹诺酮类药物BMS-284756、左氧氟沙星和环丙沙星对甲氧西林敏感及耐药金黄色葡萄球菌的杀菌活性和抗生素后效应比较
Eur J Clin Microbiol Infect Dis. 2002 Jan;21(1):27-34. doi: 10.1007/s100960100624.
10
Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.新型四环喹诺酮类药物5290对耐诺氟沙星和环丙沙星金黄色葡萄球菌菌株的抗菌活性
Chem Pharm Bull (Tokyo). 1991 Oct;39(10):2644-6. doi: 10.1248/cpb.39.2644.

引用本文的文献

1
Identification of simple arylfluorosulfates as potent agents against resistant bacteria.鉴定简单的芳基氟硫酸酯类化合物作为对抗耐药菌的有效试剂。
Proc Natl Acad Sci U S A. 2021 Jul 13;118(28). doi: 10.1073/pnas.2103513118.
2
Anthracycline Shunt Metabolites From Philippine Marine Sediment-Derived Destroy Cell Membrane Integrity of Multidrug-Resistant .来自菲律宾海洋沉积物的蒽环类分流代谢物破坏多药耐药细胞的细胞膜完整性。
Front Microbiol. 2020 Apr 24;11:743. doi: 10.3389/fmicb.2020.00743. eCollection 2020.
3
Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial.持续输注万古霉素以提高婴幼儿万古霉素目标血药浓度的随机对照试验方案:VANC试验
BMJ Open. 2018 Nov 3;8(11):e022603. doi: 10.1136/bmjopen-2018-022603.
4
Fluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?金黄色葡萄球菌感染中的氟喹诺酮类药物治疗:我们目前的状况如何?
J Lab Physicians. 2013 Jul;5(2):109-12. doi: 10.4103/0974-2727.119862.
5
Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.通过蒙特卡罗模拟评估莫西沙星在骨组织中的渗透情况。
Antimicrob Agents Chemother. 2009 May;53(5):2074-81. doi: 10.1128/AAC.01056-08. Epub 2009 Feb 17.
6
New antimicrobial agents as therapy for resistant gram-positive cocci.新型抗菌药物用于耐药革兰氏阳性球菌的治疗
Eur J Clin Microbiol Infect Dis. 2008 Jan;27(1):3-15. doi: 10.1007/s10096-007-0389-y.
7
Constant rate infusion of vancomycin in premature neonates: a new dosage schedule.早产儿万古霉素持续静脉滴注:一种新的给药方案。
Br J Clin Pharmacol. 1998 Aug;46(2):163-7. doi: 10.1046/j.1365-2125.1998.00763.x.
8
Diagnosis and management of methicillin resistant Staphylococcus aureus infection.耐甲氧西林金黄色葡萄球菌感染的诊断与管理
BMJ. 1993 Oct 23;307(6911):1049-52. doi: 10.1136/bmj.307.6911.1049.
9
TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus.TOC-39,一种新型的胃肠外使用的广谱头孢菌素,对耐甲氧西林金黄色葡萄球菌具有优异的活性。
Antimicrob Agents Chemother. 1995 May;39(5):1120-6. doi: 10.1128/AAC.39.5.1120.
10
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.通过杀菌动力学研究确定LY146032与甲氧西林、头孢唑林、头孢孟多、头孢呋辛、环丙沙星和万古霉素对葡萄球菌的活性比较。
Antimicrob Agents Chemother. 1987 Aug;31(8):1210-5. doi: 10.1128/AAC.31.8.1210.

本文引用的文献

1
Replica plating and indirect selection of bacterial mutants.细菌突变体的影印培养和间接筛选
J Bacteriol. 1952 Mar;63(3):399-406. doi: 10.1128/jb.63.3.399-406.1952.
2
Vancomycin therapy for methicillin-resistant Staphylococcus aureus.针对耐甲氧西林金黄色葡萄球菌的万古霉素治疗
Ann Intern Med. 1982 Sep;97(3):344-50. doi: 10.7326/0003-4819-97-3-344.
3
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.底特律医疗中心的社区获得性耐甲氧西林金黄色葡萄球菌心内膜炎
Ann Intern Med. 1982 Sep;97(3):330-8. doi: 10.7326/0003-4819-97-3-330.
4
Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks.社区获得性耐甲氧西林金黄色葡萄球菌感染:医院感染暴发的新来源。
Ann Intern Med. 1982 Sep;97(3):325-9. doi: 10.7326/0003-4819-97-3-325.
5
Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection.多重耐药金黄色葡萄球菌:医院感染的介绍、传播与演变
Ann Intern Med. 1982 Sep;97(3):317-24. doi: 10.7326/0003-4819-97-3-317.
6
Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌引起的医院感染流行病学
Ann Intern Med. 1982 Sep;97(3):309-17. doi: 10.7326/0003-4819-97-3-309.
7
Mechanisms of resistance to beta-lactam antibiotics in strains of Staphylococcus aureus.金黄色葡萄球菌菌株对β-内酰胺类抗生素的耐药机制
Ann Intern Med. 1982 Sep;97(3):339-44. doi: 10.7326/0003-4819-97-3-339.
8
Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors.金黄色葡萄球菌对苯唑西林最低杀菌浓度的测定:技术因素的影响及意义
Antimicrob Agents Chemother. 1983 Jan;23(1):142-50. doi: 10.1128/AAC.23.1.142.
9
In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.新型羧基喹啉抗菌剂环丙沙星的体外活性
Antimicrob Agents Chemother. 1984 Mar;25(3):331-5. doi: 10.1128/AAC.25.3.331.
10
New recommendations for disk diffusion antimicrobial susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.耐甲氧西林(异质性耐药)葡萄球菌纸片扩散法抗菌药物敏感性试验的新建议。
J Clin Microbiol. 1984 Apr;19(4):482-8. doi: 10.1128/jcm.19.4.482-488.1984.

通过时间杀菌动力学研究比较喹诺酮类抗生素和万古霉素对庆大霉素耐药及耐甲氧西林金黄色葡萄球菌的体外活性。

Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.

作者信息

Foster J K, Lentino J R, Strodtman R, DiVincenzo C

出版信息

Antimicrob Agents Chemother. 1986 Dec;30(6):823-7. doi: 10.1128/AAC.30.6.823.

DOI:10.1128/AAC.30.6.823
PMID:3643771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC180601/
Abstract

Quinolone antibiotics have been proposed as possible alternatives to vancomycin for methicillin-resistant Staphylococcus aureus infections. We investigated the activities of amifloxacin, ciprofloxacin, norfloxacin, and vancomycin by time-kill kinetic studies. Antibiotic concentrations of 0, 1.0, and 4.0 times the MIC were used against four strains of gentamicin- and methicillin-resistant S. aureus. Staphylococci were plated onto ciprofloxacin-containing agar at all time points, in repeat time-kill kinetic studies. Macrobroth dilution MICs and MBCs were determined. Ciprofloxacin levels were measured by bioassay. Replica plating was performed from the original susceptible inoculum (MIC, 0.125 micrograms/ml) onto ciprofloxacin-supplemented agar. At 4.0 times the MIC, only with ciprofloxacin was there regrowth at 24 and 48 h. All four strains of staphylococci grew on agar supplemented with 1 microgram of ciprofloxacin per ml; three of four grew on agar supplemented with 2 micrograms of ciprofloxacin per ml. MICs and MBCs for these resistant clones ranged from 8 to 32 micrograms/ml. No degradation in activity or amount of ciprofloxacin could be detected in the bioassay. Replica-plated staphylococci grew on agar containing 1 microgram/ml but not higher concentrations of ciprofloxacin at 48 h. Amifloxacin and norfloxacin sustained bactericidal activity comparable to that of vancomycin. We conclude that heteroresistant subpopulations of gentamicin- and methicillin-resistant S. aureus can emerge under antibiotic selection pressure. Such resistant clones may then mutate in the presence of subinhibitory concentrations of antibiotic to higher levels of ciprofloxacin resistance.

摘要

喹诺酮类抗生素已被提议作为耐甲氧西林金黄色葡萄球菌感染时替代万古霉素的可能选择。我们通过时间杀菌动力学研究考察了阿米氟沙星、环丙沙星、诺氟沙星和万古霉素的活性。使用0、1.0和4.0倍MIC的抗生素浓度作用于4株耐庆大霉素和耐甲氧西林的金黄色葡萄球菌。在重复的时间杀菌动力学研究中,在所有时间点将葡萄球菌接种到含环丙沙星的琼脂平板上。测定了微量肉汤稀释法的MIC和MBC。通过生物测定法测量环丙沙星水平。从原始敏感接种物(MIC,0.125微克/毫升)进行影印接种到补充环丙沙星的琼脂平板上。在4.0倍MIC时,仅环丙沙星在24小时和48小时出现再生长。所有4株葡萄球菌在每毫升补充1微克环丙沙星的琼脂上生长;4株中有3株在每毫升补充2微克环丙沙星的琼脂上生长。这些耐药克隆的MIC和MBC范围为8至32微克/毫升。在生物测定中未检测到环丙沙星的活性或量有降解。影印接种的葡萄球菌在48小时时能在含1微克/毫升但不含更高浓度环丙沙星的琼脂上生长。阿米氟沙星和诺氟沙星维持了与万古霉素相当的杀菌活性。我们得出结论,在抗生素选择压力下,耐庆大霉素和耐甲氧西林的金黄色葡萄球菌可能会出现异质性耐药亚群。然后,这种耐药克隆可能在亚抑菌浓度的抗生素存在下发生突变,对环丙沙星产生更高水平的耐药性。